Synonyms: BI 907828 | BI-907828 | BI907828 | example Ia-34 [WO2017060431A1]
Compound class:
Synthetic organic
Comment: BI 907828 is a small molecule that disrupts the protein-protein interaction between the tumour suppressor p53 and MDM2 (a p53 repressor protein) [1]. Antagonising this interaction is proposed to block proteosomal degradation of p53 protein, which is expected to re-activate p53-mediated induction of tumour cell apoptosis. The chemical structure was disclosed during the 'First Disclosures of New Drug Candidates' session at the April 2023 (Orlando) meeting of the AACR, and it maps to PubChem CID 129264140, and to the proposed INN brigimadlin.
|
|
Classification | |
Compound class | Synthetic organic |
International Nonproprietary Names | |
INN number | INN |
12473 | brigimadlin |
Synonyms |
BI 907828 | BI-907828 | BI907828 | example Ia-34 [WO2017060431A1] |
Database Links | |
BindingDB Ligand | 454378 |
CAS Registry No. | 2095116-40-6 (source: WHO INN record) |
GtoPdb PubChem SID | 479821417 |
PubChem CID | 129264140 |
Search Google for chemical match using the InChIKey | AMTXDBGKYPDTTA-SJVQGLCSSA-N |
Search Google for chemicals with the same backbone | AMTXDBGKYPDTTA |
Search PubMed clinical trials | brigimadlin |
Search PubMed titles | brigimadlin |
Search PubMed titles/abstracts | brigimadlin |
UniChem Compound Search for chemical match using the InChIKey | AMTXDBGKYPDTTA-SJVQGLCSSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | AMTXDBGKYPDTTA-SJVQGLCSSA-N |